We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

VEND:EURONEXT OSLOVend Marketplaces ASA Analysis

Data as of 2026-07-17 - not real-time

NOK 252.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

VEND MARKETPLACES ASA is trading at NOK 252, comfortably above its 20‑day (242.9) and 50‑day (243.6) simple moving averages but still under the 200‑day average of 270.6, indicating short‑term momentum within a longer‑term downtrend. The MACD is bullish (line 0.78 above signal) and the RSI sits at 58, suggesting no immediate overbought pressure, yet volume has been decreasing and the computed trend direction is listed as bearish. Market sentiment is extremely positive, with the Fear & Greed Index at 91.5 ("Extreme Greed"), while volatility remains high at nearly 29% over the past 30 days, and beta is low (≈0.31), implying the stock moves less than the market but with pronounced price swings.
Fundamentally, the company posted modest 1.6% revenue growth to NOK 6.34 bn, but profitability is weak – a gross margin of 62% masks a net loss margin of –42% and a negative ROE of –16.8%. Cash balances (NOK 5.62 bn) exceed debt (NOK 2.81 bn), yet the debt‑to‑equity ratio is high at 15.7, reflecting leverage concerns. Valuation metrics are stretched: the forward P/E of 24.1 sits well above the industry average of 16.4, and the DCF‑derived fair value of NOK 124 is less than half the current price, pointing to an overvalued market price. The dividend yield of 1% appears sustainable, with a payout ratio around 36% of forward earnings, but the negative earnings base and high drawdown of 42% add caution. Analysts collectively rate the stock as a "Buy" with a median target of NOK 290, implying limited upside relative to the current valuation.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD histogram and price above short‑term SMAs
  • Decreasing volume and bearish trend direction
  • Support level near NOK 230.4 providing downside cushion

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Current price well above DCF fair value and forward P/E premium
  • Negative earnings and high debt‑to‑equity ratio
  • Strong cash position offsetting leverage concerns

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • Price below 200‑day SMA indicating long‑term bearish bias
  • Overvaluation relative to fundamentals and industry peers
  • Sustained profitability challenges and high historical drawdown

Key Metrics & Analysis

Financial Health

Revenue Growth1.60%
Profit Margin-42.24%
P/E Ratio24.1
ROE-16.82%
ROA3.52%
Debt/Equity15.70
P/B Ratio3.0
Op. Cash FlowNOK2.0B
Free Cash FlowNOK1.6B
Industry P/E16.4

Technical Analysis

TrendBearish
RSI57.9
SupportNOK 230.40
ResistanceNOK 251.80
MA 20NOK 242.88
MA 50NOK 243.62
MA 200NOK 270.63
MACDBullish
VolumeDecreasing
Fear & Greed Index91.55

Valuation

Fair ValueNOK 123.82
Target PriceNOK 302.33
Upside/Downside19.97%
GradeOvervalued
TypeBlend
Dividend Yield1.00%

Risk Assessment

Beta0.31
Volatility28.83%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.